Botulinum toxin type A: all 809 studies that test it

Page 7 of 9. Open to participants first (92), then studies with results posted, then the rest; newest registration first within each.

• A Safety and Efficacy Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korean PatientsCompletedNCT02601287Phase 4
• Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Lateral Canthal LinesCompletedNCT02580370Phase 3
• An Exploratory Trial Investigating the Neurogenic Component in Psoriasis Vulgaris by Use of Botulinum Toxin ACompletedNCT02577185Phase 1
• Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Primary Axillary HyperhidrosisCompletedNCT02565732Phase 2
• Botulinim Toxin Type A Injections by Different Guidance in Stroke Patients With Spasticity on Upper ExtremitiesStatus unknownNCT02557737Phase 3
• Evaluation of Botulinum Toxin Injection Efficacy in the Treatment of Head Essential TremorCompletedNCT02555982Phase 3
• Kinematic-based BoNT-A Injections for Bilateral ETStatus unknownNCT02551848Phase 2
• Does Botulinum Toxin A Make Walking Easier in Children With Cerebral Palsy?CompletedNCT02546999Phase 4
• Does Botulinum A Toxin Help With Pain From Rotator Cuff Arthropathy?CompletedNCT02512536Phase 2
• The Effectiveness of Early Botulinum Toxin A Injection for Lower Limbs Spasticity in Subacute Stroke AdultsStatus unknownNCT02505802Phase 4
• Botulinim Toxin Type A Injections by Different Guidance in Stroke Patients With Spasticity on Lower ExtremitiesStatus unknownNCT02469948Phase 3
• Study of the Effects on Motor Recovery of Early Post-stroke Spasticity TreatmentCompletedNCT02462317Phase 4
• Botulinum Toxin Type A for Neuropathic Pain in Patients With Diabetic Peripheral PolyneuropathyTerminatedNCT02460107Early Phase 1
• Botulinum Toxin Type A Injection Into the Gastrocnemius Muscle for Treatment of Nocturnal Calf Cramps in Patients With Lumbar Spinal StenosisCompletedNCT02444351Not applicable
• Chronic Migraine Treatment With Botulinum Toxin-A: an Investigation of Functional Magnetic Resonance Imaging Changes.CompletedNCT02436499Phase 4
• Botulinum Toxin-A as a Treatment for Chronic Muscle-Related Pain in Adults With Spastic Cerebral Palsy: a Randomized Controlled TrialTerminatedNCT02434549Phase 2
• Botulinum Toxin A Injections in Patients With Fowler's SyndromeCompletedNCT02428881Phase 2/3
• Botulinum Toxin-A for Sialorrhoea Treatment in Asian Adults With Neurological DiseasesCompletedNCT02425176Phase 2/3
• Paralysis of the Orbicularis Muscle of the Eye in the Treatment for Dry EyeCompletedNCT02403219Phase 1
• Shockwaves Therapy and Botulinum Toxin for the Treatment of Spasticity in Patients With Cerebral Palsy. A Cross Over RCTCompletedNCT02400619Phase 1
• Efficacy and Safety of Botulinum Toxin Type A for Injection to Treat Glabellar LinesCompletedNCT02303002Phase 2
• Botox for Neurogenic Detrusor Overactivity and the Prevention of Autonomic Dysreflexia Following SCICompletedNCT02298660Phase 4
• Medytoxin® Treatment in Patients With Benign Masseteric HypertrophyCompletedNCT02292472Phase 2
• A Study to Evaluate Botulinum Toxin Type A for Injection（HengLi®）for Prophylactic Treatment of Chronic MigraineStatus unknownNCT02291380Phase 3
• A Study to Evaluate the Botulinum Toxin Type A for Injection(HengLi®) in Subjects With Post-stroke Upper Limb SpasticityCompletedNCT02280083Phase 3
• Botox Injection in Treatment of Chronic MigraineCompletedNCT02259075Phase 1/2
• Randomized Control Trial of the Use of Botox to Treat Chronic Scrotal PainCompletedNCT02249234Phase 2
• Safety and Efficacy Study of Botulinum Toxin for the Treatment of Glabellar Frown LinesCompletedNCT02236312Phase 2
• Treatment of Facial Flushing With Botulinum Toxin A InjectionsActive, not recruitingNCT02216838Phase 4
• Botox for Treatment of TMJ Disorder With BruxismWithdrawnNCT02202070Phase 1
• Treatment With Xeomin Versus Botox in Children With Spastic Equine and Equinovarus Foot Deformation in Pediatric Cerebral PalsyCompletedNCT02188277Phase 2
• Injection With OnabotulinumtoxinA (Botox) for the Treatment of Chronic Pelvic PainCompletedNCT02173405Phase 1
• Long-Term Study of OnabotulinumtoxinA Treatment in Adult Patients With Upper Limb SpasticityWithdrawnNCT02145689Phase 3
• Injections of Botulinum Toxin A in Treatment of Patients With Detrusor Overactivity and Impaired ContractilityCompletedNCT02135341Phase 2
• Split-Face Prospective Study Comparing Botox to Xeomin for the Treatment of Facial WrinklesCompletedNCT02122536Not applicable
• Randomization of Botox for Stent Pain and Irritative Voiding SymptomsTerminatedNCT02078895Phase 3
• ASIS for Botox in Cervical DystoniaStatus unknownNCT02074293Phase 1/2
• ASIS for Botox in Chronic MigraineStatus unknownNCT02074163Phase 1/2
• ASIS for Botox in Upper Limb SpasticityStatus unknownNCT02074150Phase 1/2
• Myobloc Atrophy StudyCompletedNCT02052024Phase 4
• Botox Injection in Treatment of Cluster HeadacheCompletedNCT02019017Phase 1/2
• A Pilot Study Testing Onabotulinum Toxin A Versus Incobotulinum Toxin A Injections for Facial WrinklesActive, not recruitingNCT02019004Early Phase 1
• Radiofrequency Ablation Plus Botulinum Toxin Injection Versus Radiofrequency Ablation Only in Patients With Atrial FlutterStatus unknownNCT02002962Phase 2
• Intravesical Botulinum Toxin A Injections in Treatment of Interstitial Cystitis Refractory to Conventional TreatmentCompletedNCT01969773Phase 2
• Safety of Xeomin for Lower Limb Spasticity in Multiple Sclerosis PatientsCompletedNCT01968902Phase 4
• Dose Finding Study In Subjects With Crow's FeetCompletedNCT01951742Phase 2
• A Randomized, Double Blind, Multi-center, Active Drug Controlled, Phase III Clinical Trial to Compare the Safety and Efficacy of DWP450 Versus Botox® in Treatment of Post Stroke Upper Limb SpasticityCompletedNCT01945684Phase 3
• Efficacy and Safety of Botulinum Toxin Type A for Moderate to Severe Crow's Feet LinesCompletedNCT01940991Phase 2
• Botulinum Toxin Treatment in Craniofacial, Inguinal, Palmar, Plantar and Truncal HyperhidrosisStatus unknownNCT01930604Phase 2
• OnabotulinumtoxinA for the Treatment of New Daily Persistent Headache: an Open Label StudyTerminatedNCT01920945Phase 2
• Phase III Study of Botulax® to Treat Post Stroke Upper Limb SpasticityCompletedNCT01915459Phase 3
• Botulinum Toxin Type A for Treating Allodynic Pain in SCI and MSTerminatedNCT01911377Phase 2
• Botulinum Toxin Type A Versus Saline Trigger Point Injections for Myofascial Pelvic PainStatus unknownNCT01905137Not applicable
• Early Use of Botulinum Toxin in Spasticity Post Stroke.CompletedNCT01882556Phase 2
• Efficacy and Safety of Meditoxin® Injection for Cervical Dystonia in Adults With Cerebral PalsyCompletedNCT01860196Phase 4
• Use of Botox to Treat Scrotal PainCompletedNCT01832194Phase 1
• Botulinum Toxin A to Treat Flexion Contracture After Total Knee ArthroplastyStatus unknownNCT01829087Not applicable
• Botulinum Toxin for Stomach Cancer TreatmentCompletedNCT01822210Phase 2
• Study of the Effect of Botulinum Toxin Injection in Rectus Femoris and Triceps on the Length and the Strength During Locomotion in Chronic Hemiparetic PatientsCompletedNCT01821573Phase 3
• Open Label Study to Assess Long-term Safety of Repeat Administration of Botulinum Toxin Type A for Moderate to Severe Crow's Feet LinesTerminatedNCT01818076Phase 3
• Clinical Trial to Evaluate ANT-1401 in Crow's FeetCompletedNCT01809964Phase 2
• Clinical Trial to Evaluate ANT-1403 in the Treatment of Primary Axillary HyperhidrosisCompletedNCT01799824Phase 2
• To Evaluate the Safety and Efficacy of Botulax® Are Not Inferior to Those of Botox® in the Treatment of Glabellar LinesCompletedNCT01791920Phase 3
• Phase III Clinical Trial of "Botulax®" to Treat Children With Cerebral PalsyCompletedNCT01787344Phase 3
• Efficacy and Safety Study of Botulinum Toxin Type A for Moderate to Severe Crow's Feet LinesCompletedNCT01776606Phase 3
• Effects of Intraarticular Botulinum Toxin A in Ankle OsteoarthritisCompletedNCT01760577Not applicable
• Botulinum Toxin Urethral Sphincter Injection for Dysfunctional VoidingCompletedNCT01733290Phase 2
• Botox Versus Oxybutynin as First Line Treatment for the Poorly Compliant Pediatric Neurogenic BladderCompletedNCT01716624Phase 3
• Prevention of Bladder Dysfunction in Acute Spinal Cord InjuryCompletedNCT01698138Phase 4
• Botulinum Toxin A for the Treatment of KeratoconusCompletedNCT01691651Not applicable
• Efficacy Study of Botulinum Toxin (BOTOX) Injections to Treat Vocal Fold GranulomasWithdrawnNCT01678053Phase 2
• Treatment of Plantar Fasciitis With XeominCompletedNCT01678001Phase 4
• Different Injection Number of the Same Dose of Botulinum Toxin A on Overactive Bladder SyndromeCompletedNCT01657409Phase 2
• Botulinum Toxin A for Idiopathic Toe-walkingCompletedNCT01590693Not applicable
• The Value of Botox-A for Management of Low Anterior Resection SyndromeCompletedNCT01589471Phase 2
• Comparison of Escalating Doses of IncobotulinumtoxinA (Xeomin®) in the Treatment of Glabellar RhytidsStatus unknownNCT01583478Phase 4
• Neuropathic Pain Study With Botulinum Toxin A in Spinal Cord Injury PatientsCompletedNCT01579500Phase 4
• Intraprostatic Botulinum Toxin Type "A" Injection in Patients With Benign Prostatic Hyperplasia and Unsatisfactory Response to Medical TherapyCompletedNCT01566292Phase 2/3
• Incobotulinum Toxin A for Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS)WithdrawnNCT01565395Phase 2
• Effect on Tear Functions of Pretarsal and Preseptal Techniques of Botulinum Toxin Type A Injection in Hemifacial SpasmStatus unknownNCT01564979Phase 2
• Efficacy Study of Botox for DepressionStatus unknownNCT01556971Phase 4
• Toxin Treatment for Amyotrophic Lateral Sclerosis (ALS) Related SialorrheaCompletedNCT01551940Phase 2
• Onabotulinum Toxin Type A and Abobotulinum Toxin Type A Crow's Feet Rhytid StudyCompletedNCT01529788Phase 4
• BOTOX in Men With Prostate Cancer With Lower Urinary Tract Symptoms(LUTS)/Benign Prostatic Hyperplasia (BPH)WithdrawnNCT01520441Early Phase 1
• Dose Finding Study for a Botulinum Toxin Type A Injection to Treat Habitual SnoringTerminatedNCT01515371Phase 2
• Effect of Botulinum Toxin to Hallux Valgus in Addition to Total Contact InsoleCompletedNCT01501500Phase 4
• Botulinum Toxin A for Treatment of Catocholamine Induced Finger NecrosisStatus unknownNCT01500668Phase 4
• The Biomechanical Effects of Flaccid Paralysis Induced by Botulinum Toxin a After Damage Control LaparotomyCompletedNCT01495962Phase 1
• Application of Botulinum Toxin Type A in Salivary Glands in the Treatment of Drooling in Patients With Cerebral PalsyStatus unknownNCT01489904Phase 2/3
• A Comparison Study of Oxybutynin and Botulinum Toxin for Neurogenic Detrusor OveractivityCompletedNCT01477736Not applicable
• Comparison of Two Treatments for Strabismus Correction: Botulinum Toxin A Associated to Surgery and Surgery AloneCompletedNCT01460355Phase 4
• Botulinum Toxin Injection to Treat Diffuse Esophageal SpasmStatus unknownNCT01432782Not applicable
• Botulinum Toxin to Improve Results in Cleft Lip RepairStatus unknownNCT01429402Phase 3
• The Use of Botulinum Toxin A in Two-Stage Tissue Expander/ Implant Breast ReconstructionStatus unknownNCT01427400Phase 4
• Botulinum Toxin Injections for Thoracic Outlet SyndromeStatus unknownNCT01405482Phase 1
• Brow Lifting With DysportCompletedNCT01401803Phase 4
• Effect of Botulinum Toxin Type A on Swallowing in Patients With Cervical DystoniaCompletedNCT01384214Phase 4
• Botulinum Toxin Type A for Neuroma PainWithdrawnNCT01374191Phase 2
• Clinical Trial To Evaluate ANT-1207 In Subjects With Crow's FeetCompletedNCT01358695Phase 2
• Upper Facial Remodeling With Perlane-L and DysportCompletedNCT01354743Phase 4

← Botulinum toxin type A overview